EVALUATION OF CHANGES IN COLLAGEN CONTENT IN EXPERIMENTAL CHRONIC WOUND TISSUES TREATED WITH HUMAN UMBILICAL CORD BLOOD-DERIVED PLATELET-RICH PLASMA
Main Article Content
Abstract
Objectives: To evaluate collagen content changes in experimental chronic wound tissue treated with human umbilical cord blood–derived platelet-rich plasma (hUCB-PRP). Methods: A controlled experimental and longitudinal study was conducted on 30 Sprague Dawley rats (300 - 450g) with induced chronic wounds using adriamycin, divided into 3 groups: A negative control group (NaCl 0.9%), an investigation group (hUCB-PRP), and a positive control group (Heberprot-P). Local treatment was administered at a dose of 0.2mL of hUCB-PRP per wound on days D5 and D10. Collagen proliferation was assessed through hydroxyproline (Hyp) quantification at time points D0, D5, and D21, combined with histological evaluation using Masson's tricolor staining at D21. Results: The average Hyp content of normal rat skin was 43.34 ± 3.58 mg/g of tissue. After adriamycin including the chronic wound model, Hyp levels markedly decreased and reached the lowest value at D5 (6.14 ± 0.72 mg/g of tissue). At D21, the hUCB-PRP-treated group showed significantly higher hydroxyproline levels than the negative control group (16.80 ± 2.95 vs. 9.61 ± 0.52 mg/g tissue; p < 0.001). Masson’s trichrome staining demonstrated a marked increase in collagen deposition, with collagen fibers being thicker and more evenly arranged in the treated group. Conclusion: hUCB-PRP stimulates collagen proliferation and improves collagen structure in an adriamycin-induced chronic wound experimental model.
Keywords
Collagen content, Hydroxyproline, Chronic wound, Human umbilical cord blood-derived platelet-rich plasma
Article Details
References
2. Jabbar AA, Ahmed KAA, Abdulla MA, et al. Sinomenine accelerate wound healing in rats by augmentation of antioxidant, anti-inflammatory, immunuhistochemical pathways. Heliyon. 2024; 10(1).
3. Nguyễn Thu Trang, Phạm Xuân Thắng, Lương Thị Kỳ Thủy và CS. Nghiên cứu hình thái siêu cấu trúc của vết loét mạn tính trên động vật thực nghiệm được điều trị bằng bài thuốc GTK108. Tạp chí Y học Thảm hoạ và Bỏng. 2023; (5):73-81.
4. Murphy MB, Blashki D, Buchanan RM, et al. Adult and umbilical cord blood-derived platelet-rich plasma for mesenchymal stem cell proliferation, chemotaxis, and cryo-preservation. Biomaterials. 2012; 33(21):5308-5316.
5. Hà Phương Anh, Nguyễn Thị Cự, Phạm Võ Phương Thảo và CS. Nghiên cứu nồng độ kẽm huyết thanh máu cuống rốn ở trẻ sơ sinh đủ tháng tại Bệnh viện Trường Đại học Y - Dược Huế. Tạp chí Y Dược học, Trường Đại học Y Dược Huế. 2021; 6(11):7.
6. Rudolph R, Suzuki M and Luce JK. Experimental skin necrosis produced by Adriamycin 1, 2. Cancer Treatment Reports. 1979; 63(4):529-537.
7. Pavlovic V, Ciric M, Jovanovic V, et al. Platelet rich plasma: A short overview of certain bioactive components. Open Medicine. 2016; 11(1):242-247.
8. Ehrhart J, Sanberg PR and Garbuzova‐Davis S. Plasma derived from human umbilical cord blood: Potential cell‐additive or cell‐substitute therapeutic for neurodegenerative diseases. Journal of Cellular Molecular Medicine. 2018; 22(12):6157-6166.
9. Karas RA, Alexeree S, Elsayed H, et al. Assessment of wound healing activity in diabetic mice treated with a novel therapeutic combination of selenium nanoparticles and platelets rich plasma. Scientific Reports. 2024; 14(1):5346.
10. Lee J, Jang H, Park S, et al. Platelet-rich plasma activates AKT signaling to promote wound healing in a mouse model of radiation-induced skin injury. Journal of Translational Medicine. 2019; 17:1-10.